About us
PANGAEA Oncology is a company focused on Precision Oncology, which offers both patients and pharmaceutical companies different services with the aim of improving the survival of cancer patients, their response to treatments, and their quality of life.
The company has two main areas of activity interrelated, such as the clinical care division and the state-of-the-art laboratory that provides services in various areas, including molecular diagnostics as a reference laboratory for both patients and industry, pre-treatment services (clinic to industry), and diagnostic consultancy.
Additionally, PANGAEA Oncology has an R&D division focused on diagnostic tools, highly focused on predictive models in liquid biopsy and massive sequencing, and development of tools for R&D applied in pre-clinical.
